Related Experiment Videos

9- and 13-hydroxy-linoleic acid possess chemotactic activity for bovine and human polymorphonuclear leukocytes

P A Henricks1, F Engels, H van der Vliet

  • 1Department of Pharmacology, Faculty of Pharmacy, University of Utrecht, The Netherlands.

Prostaglandins
|January 1, 1991
PubMed

Insights

Linoleic acid metabolites, 9-HODE and 13-HODE, attract inflammatory cells called polymorphonuclear leukocytes (PMNs) to the airways. These compounds show significant chemotactic activity, potentially playing a role in lung inflammation.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Lipid Metabolism

Background:

  • Airway inflammation, characterized by polymorphonuclear leukocytes (PMNs), is central to many lung diseases.
  • Pulmonary alveolar macrophages (PAMs) and epithelial cells release factors that recruit inflammatory cells.
  • PAMs and tracheal epithelial cells produce linoleic acid metabolites (9-HODE, 13-HODE) and arachidonic acid metabolites.

Purpose of the Study:

  • To investigate the potential chemotactic activity of 9-HODE and 13-HODE on isolated PMNs.
  • To compare the chemotactic potency of HODEs with known inflammatory mediators.

Main Methods:

  • In vitro chemotaxis assays using isolated human and bovine PMNs.
  • Dose-response analysis of 9-HODE and 13-HODE activity.
  • Comparison with arachidonic acid metabolite 15-HETE and leukotriene B4 (LTB4).

Main Results:

  • 9-HODE and 13-HODE demonstrated significant chemotactic activity for both human and bovine PMNs.
  • The chemotactic response showed a linear dose-response relationship from 10(-10) to 10(-6) M.
  • HODEs exhibited chemotactic potency comparable to 15-HETE and were approximately half as potent as LTB4 at 10(-8) M.

Conclusions:

  • Linoleic acid metabolites, 9-HODE and 13-HODE, possess direct chemotactic properties for PMNs.
  • These findings suggest a novel role for linoleic acid metabolism in mediating airway inflammation and PMN recruitment in lung diseases.

Related Concept Videos